Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 6/2021

01-12-2021 | Nutrition | Case Report

Efficient treatment of esophageal nutrition bezoars: dissolution outmatches removal—the Zurich approach

Authors: Bernhard Morell, Philipp Karl Buehler, Patrick Raphael Bader, Silvia Lang, Michael Scharl, Christoph Gubler, Fritz Ruprecht Murray

Published in: Clinical Journal of Gastroenterology | Issue 6/2021

Login to get access

Abstract

Enteral feed bezoars are difficult to treat and can lead to serious adverse events. There is no standardized treatment approach and various strategies have been suggested. We herein describe three cases of successful dissolutions of feed bezoars consisting of Promote® Fibre Plus with sodium bicarbonate 8.4% in critically ill patients. To provide the rationale for this approach, the effect of sodium bicarbonate 8.4% on enteral feed concretions was studied in vitro. First, Promote® Fibres Plus was incubated with hydrochloric acid with gradually decreasing pH values to establish a pH at which the solution solidifies. The resulting enteral feed concretion was exposed to sodium bicarbonate 8.4% and Coca Cola®. All patients were successfully treated with sodium bicarbonate 8.4% without the need of lengthy or repeat endoscopies. In vitro, Promote® Fibres Plus solidifies when acidified below a pH of 4.6. The resulting enteral feed concretions dissolved when exposed to sodium bicarbonate 8.4%. Incubation with Coca Cola® had no effect. We provide evidence that enteral feed bezoars consisting of Promote® Fibres Plus can be efficiently and safely treated with sodium bicarbonate 8.4% offering a new approach for daily patient care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Feldmann MFL, Brandt LJ. Sleisinger and Fortran’s gastrointestinal and liver disease. 9th ed. Philadelphia: Saunders; 2010. Feldmann MFL, Brandt LJ. Sleisinger and Fortran’s gastrointestinal and liver disease. 9th ed. Philadelphia: Saunders; 2010.
2.
go back to reference Mk S. Bezoars: from mystical charms to medical and nutritional management. Pract Gastroenterol. 2004;28:37–50. Mk S. Bezoars: from mystical charms to medical and nutritional management. Pract Gastroenterol. 2004;28:37–50.
3.
go back to reference Caldeira A, Casanova P, Sousa R, et al. Enteric nutrition and esophageal impactation: what relationship. Acta Med Port. 2010;23:183–90.PubMed Caldeira A, Casanova P, Sousa R, et al. Enteric nutrition and esophageal impactation: what relationship. Acta Med Port. 2010;23:183–90.PubMed
4.
go back to reference Turner JS, Fyfe AR, Kaplan DK, et al. Oesophageal obstruction during nasogastric feeding. Intensive Care Med. 1991;17:302–3.CrossRef Turner JS, Fyfe AR, Kaplan DK, et al. Oesophageal obstruction during nasogastric feeding. Intensive Care Med. 1991;17:302–3.CrossRef
5.
go back to reference Marcus EL, Arnon R, Sheynkman A, et al. Esophageal obstruction due to enteral feed bezoar: a case report and literature review. World J Gastrointest Endosc. 2010;2:352–6.CrossRef Marcus EL, Arnon R, Sheynkman A, et al. Esophageal obstruction due to enteral feed bezoar: a case report and literature review. World J Gastrointest Endosc. 2010;2:352–6.CrossRef
6.
go back to reference Irgau I, Fulda GJ. Esophageal obstruction secondary to concretions of tube-feeding formula. Crit Care Med. 1995;23:208–10.CrossRef Irgau I, Fulda GJ. Esophageal obstruction secondary to concretions of tube-feeding formula. Crit Care Med. 1995;23:208–10.CrossRef
7.
go back to reference Gupta R, Share M, Pineau BC. Dissolution of an esophageal bezoar with pancreatic enzyme extract. Gastrointest Endosc. 2001;54:96–9.CrossRef Gupta R, Share M, Pineau BC. Dissolution of an esophageal bezoar with pancreatic enzyme extract. Gastrointest Endosc. 2001;54:96–9.CrossRef
8.
go back to reference Katsanos KH, Koulouras V, Nakos G, et al. Successful management of full-length obstructing esophageal bezoars in an intensive care unit. Intensive Care Med. 2010;36:1280–1.CrossRef Katsanos KH, Koulouras V, Nakos G, et al. Successful management of full-length obstructing esophageal bezoars in an intensive care unit. Intensive Care Med. 2010;36:1280–1.CrossRef
9.
go back to reference Tawfic QA, Bhakta P, Date RR, et al. Esophageal bezoar formation due to solidification of enteral feed administered through a malpositioned nasogastric tube: case report and review of the literature. Acta Anaesthesiol Taiwan. 2012;50:188–90.CrossRef Tawfic QA, Bhakta P, Date RR, et al. Esophageal bezoar formation due to solidification of enteral feed administered through a malpositioned nasogastric tube: case report and review of the literature. Acta Anaesthesiol Taiwan. 2012;50:188–90.CrossRef
10.
go back to reference Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38:48–79.CrossRef Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38:48–79.CrossRef
11.
go back to reference Valli C, Schulthess HK, Asper R, et al. Interaction of nutrients with antacids: a complication during enteral tube feeding. Lancet. 1986;1:747–8.CrossRef Valli C, Schulthess HK, Asper R, et al. Interaction of nutrients with antacids: a complication during enteral tube feeding. Lancet. 1986;1:747–8.CrossRef
12.
go back to reference Krag M, Perner A, Wetterslev J, et al. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial. Trials. 2016;17:205.CrossRef Krag M, Perner A, Wetterslev J, et al. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial. Trials. 2016;17:205.CrossRef
13.
go back to reference Rohss K, Lind T, Wilder-Smith C. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. Eur J Clin Pharmacol. 2004;60:531–9.CrossRef Rohss K, Lind T, Wilder-Smith C. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. Eur J Clin Pharmacol. 2004;60:531–9.CrossRef
14.
go back to reference Chau JP, Thompson DR, Fernandez R, et al. Methods for determining the correct nasogastric tube placement after insertion: a meta-analysis. JBI Libr Syst Rev. 2009;7:679–760.CrossRef Chau JP, Thompson DR, Fernandez R, et al. Methods for determining the correct nasogastric tube placement after insertion: a meta-analysis. JBI Libr Syst Rev. 2009;7:679–760.CrossRef
15.
go back to reference Kindopp AS, Drover JW, Heyland DK. Capnography confirms correct feeding tube placement in intensive care unit patients. Can J Anaesth. 2001;48:705–10.CrossRef Kindopp AS, Drover JW, Heyland DK. Capnography confirms correct feeding tube placement in intensive care unit patients. Can J Anaesth. 2001;48:705–10.CrossRef
Metadata
Title
Efficient treatment of esophageal nutrition bezoars: dissolution outmatches removal—the Zurich approach
Authors
Bernhard Morell
Philipp Karl Buehler
Patrick Raphael Bader
Silvia Lang
Michael Scharl
Christoph Gubler
Fritz Ruprecht Murray
Publication date
01-12-2021
Publisher
Springer Singapore
Keyword
Nutrition
Published in
Clinical Journal of Gastroenterology / Issue 6/2021
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-021-01516-1

Other articles of this Issue 6/2021

Clinical Journal of Gastroenterology 6/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.